- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
International Journal of Otolaryngology
Volume 2013 (2013), Article ID 539642, 6 pages
Clinical and Pathological Characteristics of Organized Hematoma
1Department of Otolaryngology, Head and Neck Surgery, Faculty of Medicine, Yamagata University, 2-2-2 Iida-nishi, Yamagata 990-9585, Japan
2Department of Otorhinolaryngology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan
3Division of Medical Biochemistry, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga 840-8502, Japan
Received 13 December 2012; Accepted 13 February 2013
Academic Editor: David W. Eisele
Copyright © 2013 Nobuo Ohta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objective. To study the clinical and pathological characteristics of patients with organized hematoma with malignant features in maxillary sinuses. Subjects and Methods. This was a retrospective study of five patients who were treated surgically for organized hematoma. The preoperative CT and MRI findings were studied clinically. The expressions of CD31, CD34, and periostin in surgical samples were investigated by immunohistochemistry. Results. The clinical features of organized hematoma, such as a mass expanding from the maxillary sinus with bone destruction, resembled those of maxillary carcinoma. However, CT and MRI provided sufficient and useful information to differentiate this condition from malignancy. Surgical resection was the first-line treatment because of the presence of a firm capsule. Characteristic histopathological findings were a mixture of dilated vessels, hemorrhage, fibrin exudation, fibrosis, hyalinization, and neovascularization. The expressions of periostin, CD31, and CD34 were observed in organized hematoma of the maxillary sinus. Conclusion. The expressions of periostin, CD31, and CD34 were observed in organized hematoma of the maxillary sinus. Organized hematoma is characterized pathologically by a mixture of bleeding, dilated vessels, hemorrhage, fibrin exudation, fibrosis, hyalinization, and neovascularization. CT and MRI show heterogeneous findings reflecting a mixture of these pathological entities.
Nonneoplastic hemorrhagic lesions causing mucosal swelling and bone destruction can develop in the maxillary sinus. This type of lesion was reported in the Japanese literature in 1917 as a “blood boil of the maxillary sinus” by Tadokoro and is comparatively well known in Japan as one of the differential diagnoses of maxillary carcinoma. However, in the English literature, this type of lesion tends to be referred to as hemangioma of the maxillary sinus, organized hematoma of the maxillary sinus, or organized hematoma of the maxillary sinus mimicking tumor [1–8]. Although their clinical manifestations are very similar, the relationships between these entities have not been described.
We recently resected five such lesions and examined the associated clinical and histological features. Histologically, a combination of dilated vessels, hemorrhage, fibrin exudation, fibrosis, hyalinization, and neovascularization was characteristic. The lesion mimicked not only hematoma but also hemangioma. Therefore, either of the terms hemangioma or hematoma reflects the complete histological picture. In this paper, we report the clinicopathological characteristics of this entity and the relationship between the imaging and histopathological findings.
2. Subjects and Methods
To evaluate the clinicopathological entity of the organized hematoma, we recruited subjects with lesions that met the following criteria. (1) CT demonstrated an expanding unilateral maxillary lesion, with thinning or destruction of the surrounding bony tissue; (2) MRI demonstrated a heterogeneous mass; (3) macroscopically, a mass with a hemorrhagic and heterogeneous appearance was observed; (4) histologically, nonneoplastic tissue with mucosal hemorrhage was observed.
Of all the patients referred to our department between 1996 and 2010 with suspected maxillary tumor, five met these criteria. These patients underwent clinical evaluation, followed by either transmaxillary or endonasal endoscopic sinus surgery and histopathological examination of the resected tissue.
2.2. Immunohistochemistry to Detect CD31, CD34, and Periostin
For immunohistochemical detection of CD31, CD34, and periostin, we used the labeled streptavidin-biotin-complex (SABC) method. Deparaffinized tissue sections were rehydrated in alcohols. The sections were autoclaved for 10 min at 120°C in citrate phosphate buffer (pH 6.0) for antigen retrieval. Endogenous peroxidase activity was blocked with 0.3% for 30 min. The sections were then incubated with skim milk normal in phosphate-buffered saline (PBS) for 10 min to block nonspecific background staining. Monoclonal anti-CD31 and CD34 antibodies were purchased from Dako Japan (Tokyo, Japan). A polyclonal anti-Pendrin or anti-Periostin antibody was generated by immunising the rabbits with specific peptides. Polyclonal antibody against Pendrin was applied as a primary antibody at a dilution of 1 : 100 and incubated at 4°C overnight. Polyclonal antibody against Periostin was applied as a primary antibody at a dilution of 1 : 500 and incubated at 4°C overnight. After the sections had been washed with PBS, biotinylated goat anti-rabbit IgG was applied, and they were then incubated for 1 h at room temperature. Slides were developed by using diaminobenzidine and were counterstained with hematoxylin.
2.3. Assessment of Slides
Immunostained sections were assessed at 200x magnification under an Olympus microscope with an eyepiece reticle. Cell counts are expressed as means per high-power field (0.202 ). At least two sections were immunostained, and more than five areas were evaluated via the reticle. Results are expressed as number of positive cells per field, as follows: (−): negative; (+): fewer than 10 cells in each high-power field (); (++): 10 to 20 cells; (+++): more than 20 cells.
Patient characteristics and the clinical features of the five cases are summarized in Table 1. The age of the patients ranged from 14 to 56 years. The clinical features resembled those of maxillary carcinoma. The most frequently observed primary sign was recurrent epistaxis, although a wide variety of clinical features were observed, including nasal obstruction, cheek pain, and nasal pain. In most cases, the clinical course before diagnosis had been a for few months; however, one patient visited an ENT clinic because of hemorrhage from right nasal cavity mass and right nasal obstruction that had gradually enlarged over the course of 11 months. No patient exhibited coagulation abnormalities or reported a history of facial trauma. CT showed unilateral maxillary masses with thinning or destruction of the surrounding bony structures (Figure 1). The expansion pattern was not invasive. On MRI, the masses were well demarcated from the surrounding structures and heterogeneous in signal density on both T1-weighted, T2-weighted, and Gd-DTPA-enhanced images (Figure 2). CT and MRI provided sufficient information to differentiate these lesions from malignancy (Table 2).
A transmaxillary surgical approach was used in two patients and endonasal endoscopic sinus surgery in three patients. None of the patients required a blood transfusion as a result of intraoperative bleeding. The masses had firm capsules and were therefore removed easily, even in all cases in which the lesion extended from the maxillary sinus. Before the surgery, three patients underwent angiography, which revealed that the maxillary artery was the feeder artery. Two of the patients had strongly enhanced lesions, which were embolized with Gelform (Table 3).
Histologically, the specimens consisted of dilated vessels, hemorrhage, fibrin exudation, fibrosis, hyalinization, and neovascularization, without tumor cells (Figure 3). CD31-positive cells (endothelial cells) were identified in separate sections from each mass. CD34-positive cells (progenitors of endothelial cells) were also observed in the specimens (Figure 4). The expression of periostin was also observed in the specimens (Figure 5). These characteristic findings were generally seen in separate sections from each mass; the pattern of the mixture of findings differed among parts of the same mass, masses from the same patient, and patients. The appearance of the findings also varied among different parts of the masses and among patients. To obtain all of these findings, we needed to examine several sections from different parts of each mass (Table 4). These characteristic findings were all subepithelial, and the lining of the epithelium was intact.
Followup to date (range from 6 to 108 months) has demonstrated all patients to be free of recurrence.
Preoperative CT showed a heterogeneously enhanced mass expanding out of the maxillary sinus, with thinning or destruction of the adjacent bone. This expansion did not exhibit an invasive pattern but is commonly seen in malignancy, so the CT findings were not specific to this disease. This limitation was overcome by using MRI. MRI was able to demonstrate the apparent morphological heterogeneity of this disease and thus clearly differentiated it from neoplasms and mucoceles. A heterogeneous signal intensity on MRI was commonly observed. MRI showed thickening of the paranasal sinus mucosa surrounding the mass. The mucosa was well enhanced on T1-weighted images with contrast and had high signal intensity on T2-weighted images. These findings suggested the presence of inflammatory change due to obstruction by the lesion. In addition, the central part of the lesion had low signal intensity on T1-weighted imaging and high signal intensity on T2-weighted imaging and was well enhanced. These findings suggested that this central region contained blood with a low flow speed, thus matching the pathological finding of hematoma. The periphery was less well enhanced, thus matching the zone of fibrosis. This biphasic appearance is an important imaging aspect of this lesion and needs to be considered in the differential diagnosis before a decision is made on a treatment strategy. Recognizing the location of the hematoma preoperatively could be useful for avoiding intraoperative bleeding from the mass.
Microscopic examination revealed dilated vessels, hemorrhage, fibrin exudation, fibrosis, hyalinization, and neovascularization in the subepithelium. The appearance of these findings varied among different parts of the masses, and as for the disease etiology, Omura et al. suggest the negative spiral theory during the healing process as follows . First, a blood clot accumulates in the closed space owing to bleeding of various causes, including hemangioma formation, facial injury, or inflammation. Next, necrosis, fibrosis, and hyalinization occur in turn, and neovascularization develops as part of the biological healing processes. As a result, the new vessels become weak, and rebleeding might easily occur. To examine this negative spiral theory immunohistopathologically, CD31, CD34, and periostin were used for immunostaining. These results showed that the endothelial cells kept their structural integrity and dilated pattern in limited areas. CD 34 is expressed on the progenitors of endothelial cells and might play an important role in neovascularization and wound healing [9–11]. CD34 immunostaining showed that these endothelial cell progenitors were present in the lesions. Periostin is a regulator of fibrosis and collagen deposits, and although it has been recognized for the important role it plays in myocardial repair/remodeling following myocardial infarction , there are indicators that its overexpression in the nasal mucosa contributes to tissue repair and fibrosis. These findings may support the negative spiral theory immunohistopathologically.
Surgery is mandatory to remove the organized hematoma as first-line treatment. To differentiate the organized hematoma from a malignant tumor, the complete absence of neoplastic cells in the totally removed specimen should be confirmed [1–8]. Thus, total removal under general anesthesia is usually performed, and the surgical procedure should be chosen depending on the size of the lesion. ESS should be considered as the first line in limited lesion with adequate working space for the endoscopic operative field. In case of large lesion with thinning the bone structure of the paranasal sinuses, the transmaxillary approach should be chosen. There was little difference in the intraoperative bleeding volume between patients who received endoscopic sinus surgery (ESS) and those who underwent the transmaxillary approach. To decrease the intraoperative bleeding volume, embolization of the feeder artery is necessary if the feeder artery is identified by angiography. In our series, angiography was performed in only three patients and embolization in two. In the two patients that received embolization, the volume of intraoperative bleeding was less than that in the patients who did not receive embolization.
In summary, we have reported the distinct clinicopathological entity of organized hematoma. Organized hematoma of the maxillary sinus was characterized pathologically by a mixture of bleeding, dilated vessels, hemorrhage, fibrin exudation, fibrosis, hyalinization, and neovascularization. CT and MRI gave heterogeneous findings reflecting a mixture of these pathological conditions.
Written informed consent in Japanese was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Conflict of Interests
The authors declare that they have no conflict of interests.
N. Ohta used all the data available and wrote the majority of this report. S. Kakehata supplied the principles of surgical information in this paper. T. Kubota, T. Watanabe, T. Ito, Y. Suzuki, A. Ishida, and M. Aoyagi saw the patient in hospital and contributed the case history notes used in this paper. A. Matsubara and K. Izuhara reported and provided us with the histopathological findings and slides. All authors read and approved the final paper.
This work was supported by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Science, Sports, and Culture of Japan and Ministry of Health, Labour, and Welfare.
- H. M. Song, Y. J. Jang, Y. S. Chung, and B. J. Lee, “Organizing hematoma of the maxillary sinus,” Otolaryngology—Head and Neck Surgery, vol. 136, no. 4, pp. 616–620, 2007.
- M. Yagisawa, J. Ishitoya, and M. Tsukuda, “Hematoma-like mass of the maxillary sinus,” Acta Oto-Laryngologica, vol. 126, no. 3, pp. 277–281, 2006.
- M. Lim, S. Lew-Gor, T. Beale, A. Ramsay, and V. J. Lund, “Maxillary sinus hematoma,” Journal of Laryngology & Otology, vol. 122, pp. 210–212, 2007.
- R. R. Ricalde, A. C. E. Lim, R. A. B. Lopa, and J. M. Carnate, “A benign maxillary tumour with malignant features,” Rhinology, vol. 48, no. 2, pp. 146–149, 2010.
- B.-J. Lee, H.-J. Park, and S.-C. Heo, “Organized hematoma of the maxillary sinus,” Acta Oto-Laryngologica, vol. 123, no. 7, pp. 869–872, 2003.
- A. Tabaee and A. Kacker, “Hematoma of the maxillary sinus presenting as a mass: a case report and review of literature,” International Journal of Pediatric Otorhinolaryngology, vol. 65, no. 2, pp. 153–157, 2002.
- H. H. Unlu, C. Mutlu, S. Ayhan, and S. Tarhan, “Organized hematoma of the maxillary sinus mimicking tumor,” Auris Nasus Larynx, vol. 28, no. 3, pp. 253–255, 2001.
- G. Omura, K. Watanabe, Y. Fujishiro, Y. Ebihara, K. Nakao, and T. Asakage, “Organized hematoma in the paranasal sinus and nasal cavity-Imaging diagnosis and pathological findings,” Auris Nasus Larynx, vol. 37, no. 2, pp. 173–177, 2010.
- K. Oe, M. Miwa, Y. Sakai, S. Y. Lee, R. Kuroda, and M. Kurosaka, “An in vitro study demonstrating that haematomas found at the site of human fractures contain progenitor cells with multilineage capacity,” Journal of Bone and Joint Surgery B, vol. 89, no. 1, pp. 133–138, 2007.
- I. E. Pleşea, A. Cameniţa, C. C. Georgescu et al., “Study of cerebral vascular structures in hypertensive intracerebral haemorrhage.,” Romanian Journal of Morphology and Embryology, vol. 46, no. 3, pp. 249–256, 2005.
- S. A. Dreger, P. M. Taylor, S. P. Allen, and M. H. Yacoub, “Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves,” Journal of Heart Valve Disease, vol. 11, no. 6, pp. 875–880, 2002.
- G. Takayama, K. Arima, T. Kanaji et al., “Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals,” Journal of Allergy and Clinical Immunology, vol. 118, no. 1, pp. 98–104, 2006.